Ellington Management Group’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | – | Sell |
-28,400
| Closed | -$237K | – | 501 |
|
|
2016
Q1 | $237K | Buy |
+28,400
| New | +$237K | 0.1% | 309 |
|
|
2015
Q3 | – | Sell |
-10,281
| Closed | -$130K | – | 914 |
|
|
2015
Q2 | $130K | Buy |
+10,281
| New | +$130K | 0.03% | 635 |
|
|
2015
Q1 | – | Sell |
-10,900
| Closed | -$156K | – | 827 |
|
|
2014
Q4 | $156K | Buy |
+10,900
| New | +$156K | 0.05% | 493 |
|
|
2014
Q2 | – | Sell |
-16,200
| Closed | -$263K | – | 670 |
|
|
2014
Q1 | $263K | Buy |
16,200
+1,000
| +7% | +$16.2K | 0.08% | 418 |
|
|
2013
Q4 | $189K | Buy |
+15,200
| New | +$189K | 0.07% | 472 |
|
|
2013
Q3 | – | Sell |
-117,400
| Closed | -$949K | – | 981 |
|
|
2013
Q2 | $949K | Buy |
+117,400
| New | +$949K | 0.18% | 121 |
|